PRIMEDIKON

Flowtriever® Aspiration System.

The FlowTriever® Retrieval/Aspiration System is a first-of-its-kind, FDA‑cleared mechanical thrombectomy device purpose‑built for the minimally invasive treatment of acute pulmonary embolism. It employs large‑bore aspiration catheters and self‑expanding nitinol disks to extract thrombi in a single session, without the need for thrombolytic drugs, thereby reducing bleeding risk and ICU stays. 

Compared with catheter-directed thrombolysis, FlowTriever yields significantly fewer ICU admissions (~60 % reduction), shorter hospital stays, and fewer readmissions—all reflecting faster recovery and improved patient outcomes

ClotTriever® Αspiration System.

The ClotTriever® Thrombectomy System is a minimally invasive, FDA‑cleared and CE‑marked mechanical thrombectomy device designed for the effective treatment of deep vein thrombosis (DVT) by physically capturing and removing thrombus, completely eliminating the need for thrombolytic drugs and their associated bleeding risks. 

Utilizing an introducer sheath with an integrated funnel and a catheter equipped with a self‑expanding nitinol coring element and mesh collection bag, it achieves wall‑to‑wall clot removal in a single session across a wide range of vessel sizes, including the peripheral veins and vena cava.

Additionally, long‑term outcomes indicate significant reductions in post‑thrombotic syndrome and sustained improvements in patient quality of life

Walrus.

The Walrus Balloon Guide Catheter (BGC) by Q’Apel Medical is a sophisticated, FDA-cleared and CE-marked, advancement in neurovascular access designed specifically for acute ischemic stroke treatment.

Engineered with a generous 0.087‑inch internal diameter (ID) within a streamlined 8F+ (0.110‑inch outer diameter) profile, Walrus expertly balances the demands of proximal flow control, trackability, and support. Its compliant 11.1 mm polyurethane balloon ensures reliable vessel wall apposition, while dual radiopaque markers enhance fluoroscopic visibility, enabling physicians to navigate complex neurovasculature and optimize clot retrieval workflows.

Clinically, Walrus has earned a reputation for its versatility and compatibility. It supports a broad range of large-bore aspiration catheters, enabling high first-pass clot retrieval success rates.

Since its initial U.S. clearance in July 2019, Walrus has been increasingly adopted worldwide, with usage in over 20,000 U.S. patients and expanded access across global markets following its CE mark approval in March 2023.

Q’Apel Medical’s commitment to innovation is evident: the company continues refining access technology, crafting solutions that blend flow control, trackability, support, and access, all in one device.

Armadillo.

The Armadillo SelectFlex™ Neurovascular Access System by Q’Apel Medical is an elegantly engineered catheter designed for modern neurointerventional workflows. This low-profile 7‑French device, available in 95 cm and 105 cm lengths, features a 0.072‑inch internal diameter, making it compatible with commonly used guidewires and interventional tools. 

What truly sets Armadillo apart is its SelectFlex™ dual‑mode technology, which enables seamless transformation between a flexible, highly trackable state and a rigid, supportive profile, with just 0.2 mL of saline injected or withdrawn. This versatility supports a biaxial approach, eliminating the need for bulky tri‑axial setups and streamlining procedural complexity, whether using radial or femoral access

Armadillo’s design has earned both regulatory and clinical validation. In January 2025, it received CE Mark approval, affirming its safety and effectiveness for introducing interventional devices into neurovasculature across global markets.